| Literature DB >> 34937981 |
Lucas R Lopes1,2, Vitor Ar Miranda3, Rodrigo A Goes3, Gabriel Ga Souza3, Giuliana R Souza1, Jessica Cs Rocha1,3, Victor Ra Cossich3,4, Jamila A Perini1,2,3.
Abstract
The COVID-19 pandemic has presented significant challenges and implications for the sports community. Thus, this study aimed to describe the prevalence of COVID-19 in Brazilian athletes and identify the epidemiological, clinical, athletic, life and health factors associated with the disease in these individuals. A cross-sectional study was performed involving 414 athletes from 22 different sports using an online questionnaire from August to November 2020. The association between the athletes' characteristics and COVID-19 was evaluated using a logistic regression model. The prevalence of COVID-19 was 8.5%, although only 40% of athletes reported having been tested. Being under 27 years of age (3-fold), having children (~5-fold), having a teammate test positive for COVID-19 (2.5-fold), and smoking (14-fold) were associated with a possible higher risk of disease. Almost 20% of athletes self-reported musculoskeletal injuries during the period of the pandemic that was studied. Athletes with a university education (P = 0.02), a profession other than sports (P < 0.001), those from a low-income family (P = 0.01), and public health system users (P = 0.04) were significantly less frequently tested for COVID-19, whereas international competitors, athletes who received a wage, and athletes who had a teammate who tested positive for COVID-19 were 2-, 3-, and 15-fold more likely to be tested for COVID-19, respectively. Approximately 26% of the athletes who tested negative or were untested reported more than three characteristic COVID-19 symptoms, and 11% of athletes who tested positive for COVID-19 were asymptomatic. The identification of modifiable (have children, smoking, and teammates positively tested) and non-modifiable (age under 27 years) factors related to COVID-19 in athletes can contribute to implementing surveillance programmes to decrease the incidence of COVID-19 in athletes and its negative impacts in sports.Entities:
Keywords: Associated factors; Athletes; COVID-19; Epidemiological; Prevalence
Year: 2021 PMID: 34937981 PMCID: PMC8670804 DOI: 10.5114/biolsport.2021.106147
Source DB: PubMed Journal: Biol Sport ISSN: 0860-021X Impact factor: 4.606
FIG. 1Flowchart of the study population.
Description of the sociodemographic, sport, training, lifestyle and COVID-19 characteristics in study population (N = 414).
| Variables | N (%) |
|---|---|
|
| |
| Age ≥ 27 years old[ | 194 (47) |
| Male sex | 246 (59) |
| Blood group A[ | 139 (34) |
| White ethnicity | 209 (50) |
| Single marital status | 307 (74) |
| Having children | 100 (24) |
| Apartment housing | 248 (60) |
| Living with more people | 366 (88) |
| University education | 314 (76) |
| Family income < R$10.000 | 318 (77) |
| (U$1991.16) | |
|
| |
| Federated athletes | 328 (84) |
| Collective sports | 280 (68) |
| Parathletes | 19 (4.6) |
| Wage as an athlete | 126 (30) |
| Profession other than sports | 284 (69) |
| Sponsorship | 49 (9.4) |
| Weekly training > 15 hours[ | 145 (35) |
| Weekly training break | 171 (41) |
|
| |
| Nutritional follow-up | 280 (68) |
| Supplement usage | 245 (59) |
| Alcohol consumption | 208 (50) |
| Smoking | 26 (6.3) |
| Private health plans | 241 (58) |
| Use of public health services | 194 (47) |
| Chronic disease[ | 45 (11) |
|
| |
| Diagnosis | 167 (40) |
| Positive test results for the athlete | 35 (8.5) |
| Test performed by the team | 108 (26) |
| Teammate test positive | 183 (44) |
| Family member test positive | 298 (72) |
| Someone close died by COVID-19 | 106 (26) |
| Characteristic symptoms of COVID-19 | 233 (56) |
| ≤ 3 symptoms[ | 111 (48) |
| > 3 symptoms[ | 122 (52) |
| Suspected COVID-19 medical care[ | 15 (9.7) |
| Use of medication for COVID-19[ | 26 (18) |
| Hospitalization for COVID-19[ | 2 (1.4) |
|
| |
| Change in financial income | 267 (64) |
| Contract suspended or changed | 54 (13) |
| Adapted home training | 295 (71) |
| MSK injuries during the pandemic | 81 (20) |
| Joint injury | 34 (8.2) |
| Muscle injury | 52 (13) |
| Tendinopathy | 14 (3.4) |
MSK is musculoskeletal.
The variables were categorized by percentile according to the distribution among the athletes recruited.
Blood group A was according to the presence or absence of the Rh antigen/Rh factor.
The chronic diseases reported were cardiovascular (arterial hypertension, stroke), hepatic, metabolic (diabetes, hypercholesterolemia), renal, respiratory (asthma, chronic obstructive pulmonary disease, rhinitis, sinusitis) diseases, anxiety, atopic dermatites, glaucoma, herpetiform dermatites, hyperthyroidism, prostatic hyperplasia and sickle cell trait.
Frequency calculated according to 233 athletes who showed COVID-19 symptoms.
Frequency calculated according to information obtained from 155 suspected athletes of COVID-19.
Frequency calculated according to information obtained from 147 suspected athletes of COVID-19.
Frequency calculated according to information obtained from 144 suspected athletes of COVID-19.
FIG. 2Distribution of the tested athletes and frequency of positive tests for COVID-19 according to recruitment month: 1st month corresponds to the period from 08/21/2020 to 09/20/2020, 2nd from 09/21/2020 to 10/20/2020 and 3rd from 10/21/2020 to 11/21/2020. (A) Total athletes recruited per month. (B) Frequency and ratio between positive tests for COVID-19 by tested athletes according to recruitment months. (C) Frequency and ratio between positive tests for COVID-19 by tested athletes in the total study period.
Multivariate analysis of characteristics athletes COVID-19 tested (N and %).
| Model 1[ | COVID-19 (-) (N = 132) | COVID-19 (+) (N = 35) | P-value[ | Crude OR (CI 95%) | Adjusted OR (CI 95%) |
|---|---|---|---|---|---|
| Age ≥ 27 years old[ | 64 (48) | 15 (43) | 0.55 | 0.8 (0.4–1.7) | 0.3 (0.1–0.9) |
| Having children | 25 (19) | 12 (34) | 0.05 | 2.2 (1.0–5.1) | 4.9 (1.5–16.1) |
| Smoking | 1 (0.8) | 3 (8.6) | 0.007 | 12.3 (1.2–122.0) | 14.2 (1.2–167.0) |
| Teammate test positive | 69 (52) | 25 (71) | 0.04 | 2.3 (1.0–5.1) | 2.5 (1.0–5.9) |
|
|
|
|
|
|
|
| Apartment housing | 136 (55) | 112 (67) | 0.01 | 1.7 (1.1–2.6) | 1.7 (1.1–2.5) |
| University education | 197 (80) | 117 (70) | 0.02 | 0.6 (0.4–1.0) | 0.5 (0.3–0.9) |
| Family income[ | 200 (81) | 118 (71) | 0.01 | 0.6 (0.4–0.9) | 0.5 (0.3–0.9) |
| Wage as athlete | 48 (19) | 78 (47) | < 0.001 | 3.6 (2.3–5.6) | 3.8 (2.3–6.0) |
| Profession other than sports[ | 189 (76) | 95 (60) | < 0.001 | 0.4 (0.3–0.6) | 0.3 (0.2–0.5) |
| International competition | 104 (42) | 103 (62) | < 0.001 | 2.2 (1.5–3.3) | 2.2 (1.4–3.3) |
| Training > 15 hours[ | 66 (27) | 79 (47) | < 0.001 | 2.5 (1.6–3.7) | 2.5 (1.6–3.8) |
| Smoking | 21 (8.5) | 5 (3.0) | 0.02 | 0.3 (0.1–0.9) | 0.3 (0.1–0.8) |
| Use of public health services | 126 (51) | 68 (41) | 0.04 | 0.7 (0.4–1.0) | 0.6 (0.4–1.0) |
| Test performed by the team | 20 (8.1) | 88 (53) | < 0.001 | 12.6 (7.3–21.9) | 15.2 (8.3–27.7) |
| Teammate test positive | 89 (36) | 94 (56) | < 0.001 | 2.3 (1.5–3.4) | 2.3 (1.6–3.5) |
| > 3 symptoms[ | 64 (47) | 58 (60) | 0.04 | 1.7 (1.0–3.0) | 1.7 (1.0–3.0) |
OR is Odds ratio, CI is confidence interval.
P-value ≤ 0.05 was obtained through the Chi-squared Test (Pearson p-value).
OR adjusted by age, sex, sport group, having children, wage as athlete, smoking and teammate test positive.
OR adjusted by age, having children, smoking and teammate test positive.
The variables were categorized by percentile according to the distribution among the athletes recruited.
Family income corresponds to the athletes who monthly live on less than R$ 10,000 (U$ 1991,16).
Athletes with a parallel profession to sport.
Weekly training hours.
Frequency calculated according to information obtained from 233 athletes with characteristic symptoms of the COVID-19.
FIG. 3Characteristic symptoms of COVID-19 in the study population. (A) Frequency of asymptomatic and symptomatic among untested athletes, those who tested negative, and those who tested positive for COVID-19. (B) Distribution of the main characteristic symptoms of COVID-19 between the groups (athletes who tested positive, those who tested negative and athletes who tested positive and untested athletes). aP-value ≤ 0.05 was obtained through the chi-squared test (Pearson p-value) comparing the athletes who tested positive versus who tested negative. bP-value ≤ 0.05 was obtained through the chi-squared test (Pearson p-value) comparing the athletes who tested positive versus untested athletes.